Open AccessA Global Review of Obesity
Author(s) -
Jinchu Vijay,
Parthasarathy Natarajan,
Vinod Kumar Gokul,
Janani Alireza,
P. Mumthaj
Publication year - 2021
Publication title -
international journal of pharmaceutical sciences review and research
Language(s) - English
Resource type - Journals
ISSN - 0976-044X
DOI - 10.47583/ijpsrr.2021.v68i01.011
Subject(s) - obesity , dieting , overweight , medicine , weight loss , orlistat , body mass index , calorie , disease , appetite , environmental health , gerontology , endocrinology
Obesity is major health problem and are defined as abnormal or excessive amount of fat accumulation that presents a risk to health.A body mass index (BMI) over 24 is considered overweight, and over 30 is obese. obesity are main risk factors for a number of chronic diseases, like cardiovascular diseases such as heart disease and stroke, which are the leading causes of death worldwide. Over 800 million people around the world are living with obesity. The medical consequences of obesity will cost over $1 trillion by 2025. People living with obesity are twice as likely to be hospitalized if tested positive for COVID-19. The weight loss segments are one of the major contributors to the overall revenue of the dietary supplements in market. Anti-obesity drugs are used as pharmacological agents which reduce or control body weight. These drugs can change one of the fundamental processes of the human body or weight regulation by altering either appetite or absorption of calories. The treatment for obese patients is dieting and physical exercise. An anti-obesity drug have produce sustained weight loss with minimal side effects.